ICD-10-CM E85 is the diagnosis code for Amyloidosis. This code falls under the section "Metabolic disorders" within Chapter 4 â Endocrine, nutritional and metabolic diseases (E00-E89). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions are not included in E85. If the patient has both, code each condition separately:
Understanding where E85 sits in the ICD-10-CM classification helps ensure proper coding:
No, E85 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
E85 is the ICD-10-CM diagnosis code for "Amyloidosis". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
E85 is located in Section E70-E88 â "Metabolic disorders" within Chapter 4 of the ICD-10-CM Tabular List.
E85 has 7 sub-code(s) that provide more specific detail: E85.0, E85.1, E85.2, E85.3, E85.4 and more.
Use E85 when the patients documented diagnosis matches "Amyloidosis" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Amyloidosis is E85.
No, E85 is non-billable. Use a more specific sub-code for primary diagnosis billing.
E85 is in Chapter 4 of the ICD-10-CM Tabular List.
Yes, E85 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.